Stay updated on Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial
Sign up to get notified when there's something new on the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page.

Latest updates to the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study page now renders a 403 Forbidden error page. This replaces the study details and navigation with an access-denied screen.SummaryDifference19%

- Check17 days agoChange DetectedRevision label updated from v3.6.6 to v3.7.0, signaling a platform update. No study details or page content appear to be altered by this change.SummaryDifference0.1%

- Check31 days agoChange DetectedA new site revision number (v3.6.6) has been published, replacing the previous revision (v3.6.5).SummaryDifference0.1%

- Check52 days agoChange DetectedThe page revision updated from v3.6.4 to v3.6.5, indicating a minor update to the page's documentation or metadata. The visible study content and configuration appear unchanged.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page's revision tag has been updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a minor update to the page version. No substantive study content is changed.SummaryDifference0.1%

- Check88 days agoChange DetectedFooter updates add references to the Moffitt Clinical Trials website and H. Lee Moffitt Cancer Center and Research Institute, along with a 'Helpful Links Provided by' note. The revision marker now shows v3.6.3, replacing the previous v3.6.2.SummaryDifference0.2%

Stay in the know with updates to Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page.